Myomo, Inc.
AMEX:MYO · New York Stock Exchange American
-$0.13 today
Vol 0.69M · Avg 0.62M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
AMEX:MYO · Revenue to Net Income
Key Ratios
Analysis
$41.2M of revenue converted into -$15.1M of net income for the selected period. Gross margin is 65.8% and net margin is -36.9%, showing how much revenue survives after costs and taxes. EPS is $-0.36, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.9M +25.7% | $32.6M +69.2% | $19.2M +23.7% | $15.6M +12.3% | $13.9M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $14.0M +49.9% | $9.4M +54.6% | $6.1M +14.3% | $5.3M +49.6% | $3.5M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $26.9M +16.0% | $23.2M +75.9% | $13.2M +28.6% | $10.3M -0.6% | $10.3M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 65.7% -5.5pp | 71.2% +2.7pp | 68.5% +2.6pp | 65.9% -8.5pp | 74.4% | 9.8% | 28.9% | 38.3% |
| Research & Development | $6.9M +45.5% | $4.8M +81.0% | $2.6M +6.2% | $2.5M -2.9% | $2.6M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $34.3M +39.5% | $24.6M +31.1% | $18.8M +1.8% | $18.4M +2.3% | $18.0M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $41.3M +40.5% | $29.4M +37.3% | $21.4M +2.3% | $20.9M +1.7% | $20.6M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $1.8M +127.1% | $777.0K +50.1% | $517.7K -4.6% | $542.6K +61.5% | $336.0K | $374.2M | $1.2B | $631.8M |
| EBITDA | -$12.4M -145.5% | -$5.0M +32.5% | -$7.5M +26.1% | -$10.1M -1.6% | -$9.9M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -30.2% -14.8pp | -15.5% +23.4pp | -38.8% +26.1pp | -65.0% +6.8pp | -71.8% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$14.4M -132.0% | -$6.2M +24.6% | -$8.2M +22.9% | -$10.7M -3.9% | -$10.3M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -35.2% -16.1pp | -19.1% +23.7pp | -42.8% +25.8pp | -68.6% +5.5pp | -74.1% | 16.6% | 24.1% | 22.0% |
| Interest Income | $477.0K +22.7% | $388.6K -5.3% | $410.3K +362.4% | $88.7K +5404.4% | $1.6K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $927.8K | $0 | $0 | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$667.5K -271.8% | $388.6K +61.9% | $240.0K +1036.4% | $21.1K +237.7% | -$15.3K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$15.1M -159.0% | -$5.8M +27.2% | -$8.0M +25.0% | -$10.7M -3.6% | -$10.3M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -36.8% -18.9pp | -17.9% +23.7pp | -41.5% +26.9pp | -68.5% +5.7pp | -74.2% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $504.5K +38.0% | $365.6K +134.4% | $156.0K +123.1% | $69.9K -21.4% | $88.9K | $1.3B | -$1.6B | $745.2M |
| Net Income | -$15.6M -151.9% | -$6.2M +24.1% | -$8.1M +24.0% | -$10.7M -3.4% | -$10.4M | $4.9B | $4.8B | $4.7B |
| Net Margin | -38.1% -19.1pp | -19.0% +23.3pp | -42.3% +26.6pp | -68.9% +5.9pp | -74.9% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$0 -131.3% | -$0 +42.9% | -$0 +81.6% | -$2 +14.6% | -$2 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$0 -131.3% | -$0 +42.9% | -$0 +81.6% | -$2 +14.6% | -$2 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $41.9M +10.8% | $37.8M +29.8% | $29.1M +312.7% | $7.1M +20.9% | $5.8M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $41.9M +10.8% | $37.8M +28.0% | $29.5M +318.3% | $7.1M +20.9% | $5.8M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
electroCore, Inc.
NASDAQ:ECOR
$67.78M
Precision Optics Corporation, Inc.
POCI
$44.90M
MIRA Pharmaceuticals, Inc.
MIRA
$40.43M
Milestone Scientific Inc.
MLSS
$30.39M
NeuroOne Medical Technologies Corporation
NMTC
$27.85M
IGC Pharma, Inc.
IGC
$27.70M
Hyperion DeFi, Inc.
HYPD
$17.02M
Modular Medical, Inc.
MODD
$8.88M
Nexalin Technology, Inc.
NXL
$8.03M
Vicarious Surgical Inc.
RBOT
$1.60M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does MYO generate?
Myomo, Inc. (MYO) reported $40.93M of revenue in fiscal 2025.
Is MYO profitable?
Myomo, Inc. (MYO) reported -$15,573,884.00 of net income, with a net margin of -38.1%.
Explore More
Continue the stock analysis
Jump to another research area for this company.